Catheter Precision Inc (NYSE American: VTAK) Marks Milestone: VIVO Used Successfully with Pediatric Patient

The medical equipment sector is presently highly coveted by investors, and if you’re exploring companies in this field, consider investigating Catheter Precision Inc. (NYSE American: VTAK). This U.S.-based medical device firm specializes in electrophysiology products and recently unveiled a significant announcement. 

On Wednesday, February 28, 2024, Catheter Precision, Inc. (NYSE American: VTAK) experienced an 8.69% increase, closing higher than usual trading volumes. This marks the third consecutive day of gains, forming a Bullish Swing Set-up alongside other positive indicators. Furthermore, the stock is currently trading above its 10, 20, and 50-day moving averages. With VTAK’s 52-week high at $2.80, breaking its 200-day moving average of $0.60 could potentially propel the stock to even greater heights. 

The corporation disclosed that its product, VIVO, was utilized for the inaugural time on a pediatric patient in Turkey. This revelation surfaced shortly after Catheter Precision declared a fresh distribution collaboration with Ege Artimi, a company operating in the Turkish market, just last month. 

David Jenkins, the CEO, commented on this advancement, emphasizing that VIVO stands out as a premier device designed for pre-procedure planning in pediatric cases. This non-invasive tool is particularly useful before ventricular ablations, offering tailored patient-specific information to physicians without additional risk. Jenkins highlighted that deploying VIVO in sensitive patients showcases its adaptability and diverse advantages. 

The corporation primarily focuses on pioneering technology for electrophysiology procedures, achieved through impactful partnerships with physicians, which foster ongoing enhancements in its offerings. Initially established as Ra Medical in Delaware in 2018, the company rebranded as Catheter Precision Inc. on August 17, 2023. VIVO stands out as one of its key products, having already garnered substantial traction across various markets. The company aims to expand the product’s reach into additional markets.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com


Posted

in

by

Tags: